ES8704495A1 - Un procedimiento para la preparacion de un derivado tetraci-clico de espirohidantoina biologicamente activo. - Google Patents

Un procedimiento para la preparacion de un derivado tetraci-clico de espirohidantoina biologicamente activo.

Info

Publication number
ES8704495A1
ES8704495A1 ES546093A ES546093A ES8704495A1 ES 8704495 A1 ES8704495 A1 ES 8704495A1 ES 546093 A ES546093 A ES 546093A ES 546093 A ES546093 A ES 546093A ES 8704495 A1 ES8704495 A1 ES 8704495A1
Authority
ES
Spain
Prior art keywords
formula
hydantoin
reductase inhibitors
aldose reductase
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES546093A
Other languages
English (en)
Other versions
ES546093A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES546093A0 publication Critical patent/ES546093A0/es
Publication of ES8704495A1 publication Critical patent/ES8704495A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/16—Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/88—Unsaturated compounds containing keto groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR UN DERIVADO TETRACICLICO DE ESPIROHIDANTOINA BIOLOGICAMENTE ACTIVO. CONSISTE EN HACER REACCIONAR UNA AMINA INTERMEDIA DE FORMULA (II) CON UNA A-CETOACIDO ESTER DE FORMULA (III), EN PRESENCIA DE ACIDO CLORHIDRICO CONCENTRADO O ACIDO GLACIAL, PARA FORMAR UN COMPUESTO DE FORMULA (I) Y SUS SALES DE ADICION DE ACIDOS FARMACEUTICAMENTE ACEPTABLES. SIENDO: M, H, ALQUILO DE C 1 A 4 Y OTROS; R, H, ALQUILO DE C 1 A 9 Y OTROS; Y X, H, F, CL Y OTROS. SE UTILIZA PARA EL TRATAMIENTO DE LAS COMPLICACIONES DE LA DIABETES CRONICA.
ES546093A 1984-08-14 1985-08-12 Un procedimiento para la preparacion de un derivado tetraci-clico de espirohidantoina biologicamente activo. Expired ES8704495A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1984/001290 WO1986001107A1 (en) 1984-08-14 1984-08-14 Tetracyclic spiro-hydantoin aldose reductase inhibitors, compositions and methods of making

Publications (2)

Publication Number Publication Date
ES546093A0 ES546093A0 (es) 1987-04-01
ES8704495A1 true ES8704495A1 (es) 1987-04-01

Family

ID=22182231

Family Applications (2)

Application Number Title Priority Date Filing Date
ES546093A Expired ES8704495A1 (es) 1984-08-14 1985-08-12 Un procedimiento para la preparacion de un derivado tetraci-clico de espirohidantoina biologicamente activo.
ES551963A Expired ES8801831A1 (es) 1984-08-14 1986-02-13 Un procedimiento para la preparacion de un derivado tetraciclico de espiro-hidantoina biologicamente activo

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES551963A Expired ES8801831A1 (es) 1984-08-14 1986-02-13 Un procedimiento para la preparacion de un derivado tetraciclico de espiro-hidantoina biologicamente activo

Country Status (24)

Country Link
US (1) US4656169A (es)
EP (1) EP0173497B1 (es)
JP (1) JPS6147486A (es)
KR (1) KR870000624B1 (es)
AT (1) ATE46162T1 (es)
AU (1) AU553699B2 (es)
CA (1) CA1255304A (es)
DD (1) DD236529A5 (es)
DE (1) DE3572818D1 (es)
DK (1) DK366685A (es)
ES (2) ES8704495A1 (es)
FI (1) FI82695C (es)
GR (1) GR851968B (es)
IE (1) IE58123B1 (es)
IL (1) IL76076A0 (es)
IN (2) IN166581B (es)
NO (1) NO164101C (es)
NZ (1) NZ213085A (es)
PH (1) PH22910A (es)
PL (2) PL145221B1 (es)
PT (1) PT80940B (es)
WO (1) WO1986001107A1 (es)
YU (1) YU44894B (es)
ZA (1) ZA856102B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202339A (en) * 1987-08-28 1993-04-13 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
US5004751A (en) * 1987-08-28 1991-04-02 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
WO1990002126A1 (en) * 1988-08-24 1990-03-08 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
TW202450B (es) * 1991-06-26 1993-03-21 Dainippon Pharmaceutical Co

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4193996A (en) * 1979-04-04 1980-03-18 Pfizer Inc. Spiro-quinolone hydantoins
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives

Also Published As

Publication number Publication date
ATE46162T1 (de) 1989-09-15
US4656169A (en) 1987-04-07
NO164101C (no) 1990-08-29
EP0173497B1 (en) 1989-09-06
IE851991L (en) 1986-02-14
NO164101B (no) 1990-05-21
NZ213085A (en) 1988-03-30
FI82695B (fi) 1990-12-31
ZA856102B (en) 1987-03-25
ES551963A0 (es) 1988-02-16
FI861544A (fi) 1986-04-11
ES546093A0 (es) 1987-04-01
FI82695C (fi) 1991-04-10
YU129085A (en) 1988-04-30
PL147875B1 (en) 1989-08-31
ES8801831A1 (es) 1988-02-16
KR860001811A (ko) 1986-03-22
AU4612685A (en) 1986-02-20
PT80940B (pt) 1987-12-30
PL261413A1 (en) 1988-01-21
IL76076A0 (en) 1985-12-31
JPS6147486A (ja) 1986-03-07
PH22910A (en) 1989-01-24
YU44894B (en) 1991-04-30
AU553699B2 (en) 1986-07-24
PT80940A (en) 1985-09-01
DK366685A (da) 1986-02-15
DE3572818D1 (en) 1989-10-12
WO1986001107A1 (en) 1986-02-27
IE58123B1 (en) 1993-07-14
DD236529A5 (de) 1986-06-11
DK366685D0 (da) 1985-08-13
KR870000624B1 (ko) 1987-03-26
PL254960A1 (en) 1987-01-12
JPH0339512B2 (es) 1991-06-14
CA1255304A (en) 1989-06-06
NO861425L (no) 1986-04-11
IN166581B (es) 1990-06-09
PL145221B1 (en) 1988-08-31
EP0173497A1 (en) 1986-03-05
GR851968B (es) 1985-12-13
IN166590B (es) 1990-06-09
FI861544A0 (fi) 1986-04-11

Similar Documents

Publication Publication Date Title
ES8603455A1 (es) Un metodo para preparar derivados de piperazina
IE790210L (en) Alkylenediamine derivatives
CA2304713A1 (en) Biphenyl-5-alkanoic acid derivatives and use thereof
ES8600264A1 (es) Un procedimiento para la preparacion de nuevos derivados de furanona
DK144690D0 (da) Fremgangsmaade til fremstilling af 7-substituerede hept-6-en- og -heptansyrer og derivater og mellemprodukter deraf
ES2066140T3 (es) Derivados de acidos 7-ceto- y 7-hidroxi-androsta-3,5-dieno-3-carboxilicos.
ES8704153A1 (es) Un procedimiento para preparar derivados de pirimidina
ES8704495A1 (es) Un procedimiento para la preparacion de un derivado tetraci-clico de espirohidantoina biologicamente activo.
ES454086A1 (es) Procedimiento para la preparacion de n-(r-tetrahidrofurfu- ril)-noroximorfona y n-(s-tetrahidrofurfuril)-norosimorfona nuevas.
NO162421C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylinderivater og syreaddisjonssalter derav.
NO178025C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive (benzhydryloksyetylpiperidyl)alifatiske syrederivater
GB1514389A (en) Glycerides with antibacterial properties
FI861947A (fi) Hexensyror.
ES8703475A1 (es) Un procedimiento para la preparacion de derivados de 5-cetomilbemicina.
ES8601910A1 (es) Un procedimiento para preparar nuevos derivados amidinicos de 4-fenilimidazol sustituido en la posicion 2
ES401589A1 (es) Procedimiento para la preparacion de nuevas 2-(5-nitro-2- furil) - tieno (2,3-d) pirimidinas.
DE3685942D1 (de) 2-pyridylessigsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
NO860114L (no) Imidazolderivater og fremgangsmaate til fremstilling derav.
HUT50461A (en) Process for producing imidazole derivatives inhibiting dopamin-beta-hydroxylase and pharmaceutical compositions comprising such compounds
ES8602789A1 (es) Procedimiento para preparar derivados de 14-hidroxiimino- eburnano racemicos y opticamente activos
IT1253007B (it) Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
NO167382C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-hydroxy-4-(substituerte alkenyl)cyklohexancarboxylsyrer.
KR890003725A (ko) 아민유도체 및 이의 염, 이의 제조방법 및 이를 함유하는 궤양치료제
ES471169A1 (es) Un procedimiento para la obtencion de 2-p-clorofenil-1,3,3- trimetil- 4-metilenpiperidina
EP0370974A3 (en) Process for preparing heterocyclic derivatives

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970612